Goodwin Advises insitro in Strategic Collaboration With AstraZeneca for AI-enabled Discovery of Novel Therapeutics for MASH and Cardiomyopathies
October 15, 2026
October 15, 2026
BOSTON, Massachusetts, Oct. 15 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:
* * *
Goodwin Advises insitro in Strategic Collaboration With AstraZeneca for AI-enabled Discovery of Novel Therapeutics for MASH and Cardiomyopathies
*
The Life Sciences team advised insitro on its worldwide exclusive research collaboration agreement with AstraZeneca to discover novel targets and therapeutics in metabolic dysfunct . . .
* * *
Goodwin Advises insitro in Strategic Collaboration With AstraZeneca for AI-enabled Discovery of Novel Therapeutics for MASH and Cardiomyopathies
*
The Life Sciences team advised insitro on its worldwide exclusive research collaboration agreement with AstraZeneca to discover novel targets and therapeutics in metabolic dysfunct . . .